Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
Rachel L. Berry(Western General Hospital), Peter Hohenstein(Roslin Institute), Tatiana Dudnakova(Western General Hospital), Chris Armit(University of Edinburgh), Seppo Vainio(University of Oulu), Derya D. Ozdemir(Roslin Institute), Nicholas D. Hastie(Western General Hospital), Richard Baldock(Western General Hospital), Bruce J. Aronow(Cincinnati Children's Hospital Medical Center), Jingdong Shan(University of Oulu), Anna Thornburn(Western General Hospital), Marc Jeanpierre(Délégation Paris 5), David G. Brownstein(The Queen's Medical Research Institute), Anagha Joshi(University of Cambridge), Jamie A. Davies(University of Edinburgh), Nils O. Lindström(University of Southern California), James Baily(The Queen's Medical Research Institute), Paul Perry(Western General Hospital)
Cited by 13
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
|Nucleic Acids Research|2015|1k
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
|Nature Genetics|2008|806
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712